Table 3.
Diagnostic yield of different modalities, treatment methods, histopathological findings, and clinical outcomes of patients with Meckel's diverticulum diagnosed by BAE (n = 55).
| Patient characteristics | No. of patients (%) |
|---|---|
| Diagnostic procedure used | |
| BAE | 55 (100) |
| Abdominal CT | 49 (89.1) |
| Meckel's scan | 29 (52.7) |
| Small bowel series | 16 (29.1) |
| Capsule endoscopy | 11 (20) |
| Digital angiography | 9 (16.4) |
| Yield of diagnostic procedure | |
| BAE | 55/55 (100) |
| Capsule endoscopy | 5/11 (45.5) |
| Meckel's scan | 10/29 (35.7) |
| Abdominal CT | 7/49 (14.6) |
| Small bowel series | 2/16 (12.5) |
| Digital angiography | 1/9 (11.1) |
| Treatment methods | |
| Surgical treatment | 42 (76.4) |
| Conservative treatment | 13 (23.6) |
| Heterotopic tissue# | |
| Gastric mucosa | 19 (42.4) |
| Gastric and pancreatic tissues | 3 (7) |
| Pancreatic tissue | 2 (4.7) |
| Colonic mucosa | 1 (2.3) |
| Neuroendocrine tumor | 1 (2.3) |
| No | 17 (39.5) |
BAE: balloon-assisted enteroscopy; CT: computed tomography. #43 patients with endoscopic biopsies or surgical resection specimens of Meckel's diverticulum.